Open access
Open access
Powered by Google Translator Translator

FDA Safety Alert: Drug to Treat Ulcerative Colitis and Arthritis May Increase the Risk of Blood Clots and Death with Higher Dose

29 Jul, 2019 | 20:19h | UTC

FDA Drug Safety Communication: FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR) – U.S. Food & Drug Administration (free)

Commentary: Boxed Warnings Added to Drug for Ulcerative Colitis, Arthritis – NEJM Journal Watch (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.